TheraNovex Unveils AI-Powered Eligibility Screener Tool

Automated pre-screening reduces participant qualification time by 80% and improves recruitment efficiency

TheraNovex today announced the launch of its intelligent Eligibility Screener, a breakthrough tool that automates participant pre-qualification for clinical trials. This AI-powered solution analyzes participant responses in real-time, instantly determining study eligibility and reducing manual screening time by up to 80%.

Revolutionizing Pre-Screening Process

Traditional clinical trial screening processes often require multiple phone calls, manual document reviews, and time-consuming assessments that can take days or weeks to complete. The TheraNovex Eligibility Screener transforms this process by providing instant, accurate eligibility determinations through sophisticated AI algorithms that analyze participant responses against complex inclusion and exclusion criteria.

"Manual screening has been a significant bottleneck in clinical trial recruitment for decades," said Dr. Jennifer Martinez, Chief Technology Officer at TheraNovex. "Our AI-powered screener not only dramatically reduces the time to qualification but also improves accuracy and provides a better experience for both participants and research teams."

How the AI Screener Works

The TheraNovex Eligibility Screener leverages advanced machine learning algorithms to:

• Analyze participant responses against study-specific criteria in real-time
• Identify potential matches based on medical history and demographics
• Flag complex cases that require human review
• Generate detailed eligibility reports for research coordinators
• Integrate seamlessly with existing trial management systems

Pilot Program Results

During a three-month pilot program conducted across 12 research sites, the TheraNovex Eligibility Screener demonstrated remarkable improvements in recruitment efficiency:

Advanced Analytics and Insights

Beyond individual screening, the platform provides comprehensive analytics that help research teams optimize their recruitment strategies. The system tracks screening success rates, identifies common exclusion criteria, and provides insights into participant demographics to improve future trial design and targeting.

Compliance and Security

The AI Eligibility Screener is built with strict compliance and security standards. All participant data is processed in accordance with HIPAA regulations, and the platform maintains comprehensive audit trails for regulatory compliance. The system also includes role-based access controls and encrypted data transmission to ensure participant privacy and data security.

Integration and Implementation

The TheraNovex Eligibility Screener integrates seamlessly with existing clinical trial management systems and can be customized for specific study requirements. Implementation typically takes 1-2 weeks and includes comprehensive training for research staff, technical support, and ongoing optimization based on usage patterns.

"We're committed to making clinical trials more efficient and accessible," added Sarah Thompson, VP of Product Development at TheraNovex. "The AI Eligibility Screener represents a significant advancement in how we approach participant recruitment and screening."